Highlights
AMEX: ATNM       Actinium Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
7.74   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):193,500
4 Weeks Range:7.65 - 9.68
4 Weeks Price Volatility (%):
79.96%
52 Weeks Range:5.70 - 13.182
52 Weeks Price Volatility (%):
58.72%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1523  2897  172  6898 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 TLGT 0.174-0.028 
 BKKT 24.241-6.359 
 RPAI 13.15-0.43 
 TSLA 1,024.22-0.64 
 NIO 41.005-0.265 
 FB 314.055-14.635 
 F 15.73-0.27 
 PLTR 25.86+0.45 
 INTC 47.964-1.446 
 AMD 123.98+1.62